1. Home
  2. PKOH vs NTHI Comparison

PKOH vs NTHI Comparison

Compare PKOH & NTHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Park-Ohio Holdings Corp.

PKOH

Park-Ohio Holdings Corp.

HOLD

Current Price

$25.34

Market Cap

299.5M

Sector

Industrials

ML Signal

HOLD

NTHI

NeOnc Technologies Holdings Inc.

HOLD

Current Price

$9.35

Market Cap

243.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PKOH
NTHI
Founded
1907
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
299.5M
243.9M
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
PKOH
NTHI
Price
$25.34
$9.35
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$37.00
N/A
AVG Volume (30 Days)
23.2K
38.1K
Earning Date
06-11-2026
01-01-0001
Dividend Yield
1.80%
N/A
EPS Growth
N/A
N/A
EPS
1.70
N/A
Revenue
$1,599,100,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.72
N/A
P/E Ratio
$17.61
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.52
$3.20
52 Week High
$29.50
$16.00

Technical Indicators

Market Signals
Indicator
PKOH
NTHI
Relative Strength Index (RSI) 48.85 49.16
Support Level $19.01 $8.29
Resistance Level $28.50 $10.96
Average True Range (ATR) 1.32 0.76
MACD -0.22 -0.06
Stochastic Oscillator 7.06 50.91

Price Performance

Historical Comparison
PKOH
NTHI

About PKOH Park-Ohio Holdings Corp.

Park-Ohio Holdings Corp is a company, engaged in industrial supply chain logistics and diversified manufacturing business. It operates in three business segments namely Supply Technologies, Assembly Components and Engineered Products. Geographically, the business of the group is amplifying across the region of the United States, Asia, Europe, Canada, Mexico and others. The company derives key revenue from the Supply Technologies segment which includes proactive solutions approach that manages the efficiencies of every aspect of supplying production parts and materials to customers' manufacturing floor, from strategic planning to program implementation.

About NTHI NeOnc Technologies Holdings Inc.

NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration (FDA).

Share on Social Networks: